Successful completion of Phase I SME Instrument Horizon 2020 project

The Comac Medical Horizon 2020 team successfully completed phase I SME Instrument Horizon 2020 project, on the topic: “Improving diagnostics of respiratory diseases and boosting the COMAC MEDICAL competitiveness and growth by validation of fractional EBT biomarker through new method of measurement and device.”

As a result, Comac Medical submitted a final report, containing the details and the results of the feasibility study which proved the commercial potential and significant innovativeness of the project idea. The SME received positive outcomes from the freedom-to-operate analysis and is in a process of obtaining an IP protection at UK, European and international level.

The final report was approved by the European commission – Executive Agency for SMEs and on the basis of the successful completion of Phase I SME Instrument project, Comac Medical started the preparation of Phase II.

Due to the successful completion of Phase I, Comac Medical contributed to the positioning of Bulgaria on the map of the SME Instrument of Horizon 2020 by creating innovation that would improve the life of millions of patients with pulmonary diseases in EU and beyond.

For more information, please see: